Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Parexel Intl Cp (PRXL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 3,252,777
  • Shares Outstanding, K 50,960
  • Annual Sales, $ 2,426 M
  • Annual Income, $ 154,900 K
  • 36-Month Beta 0.75
  • Price/Sales 1.33
  • Price/Cash Flow 11.85
  • Price/Book 6.31

Price Performance

See More
Period Period Low Period High Performance
1-Month
60.51 +5.49%
on 04/19/17
63.96 -0.20%
on 04/28/17
+1.13 (+1.80%)
since 03/28/17
3-Month
60.51 +5.49%
on 04/19/17
71.30 -10.48%
on 01/31/17
-6.25 (-8.92%)
since 01/27/17
52-Week
51.16 +24.77%
on 11/11/16
72.32 -11.74%
on 01/13/17
+3.25 (+5.36%)
since 04/28/16

Most Recent Stories

More News
Parexel International Announces Date of Third Quarter Fiscal Year 2017 Earnings Release and Conference Call

PAREXEL International Corporation (NASDAQ: PRXL) will release financial results for the Third Quarter Fiscal Year 2017 on Wednesday, May 3, 2017 after the close of the stock market.

PRXL : 63.83 (+0.73%)
PAREXEL Ranked a Top CRO in CenterWatch Global Investigative Site Relationship Survey

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced that it was named a top contract research organization (CRO) in...

PRXL : 63.83 (+0.73%)
PAREXEL (PRXL) Launches Sensor for Clinical Trial Market

PAREXEL International Corporation (PRXL), a global biopharmaceutical services company and provider of clinical research and logistics, recently announced the launch of its patient sensor solution.

PRXL : 63.83 (+0.73%)
IDXX : 167.73 (+3.05%)
INGN : 82.89 (-0.85%)
FLDM : 4.94 (-2.76%)
PAREXEL Launches Patient Sensor Solution to Transform Clinical Trial Data Collection

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today announced the launch of its patient sensor solution, a new offering that securely...

PRXL : 63.83 (+0.73%)
First Week of May 19th Options Trading For PAREXEL International (PRXL)

Investors in PAREXEL International Corp. saw new options become available this week, for the May 19th expiration.

PRXL : 63.83 (+0.73%)
PAREXEL International is Now Oversold (PRXL)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical...

PRXL : 63.83 (+0.73%)
Watch for Parexel International to Potentially Rebound After Falling 1.15% Yesterday

Parexel International (NASDAQ:PRXL) traded in a range yesterday that spanned from a low of $63.37 to a high of $64.54. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low...

PRXL : 63.83 (+0.73%)
PAREXEL Named a FlexJobs Top 100 Company to Watch for Telecommuting and Remote Jobs in 2017

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organization, today announced that it has been named to the FlexJobs Top 100 Companies to Watch...

PRXL : 63.83 (+0.73%)
PAREXEL Launches ClinPhone RTSM Mobile App to Improve Supply Management and Increase Patient Safety

PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services provider, today launched a mobile app for the ClinPhone(R) RTSM (randomization and trial supply...

PRXL : 63.83 (+0.73%)
PAREXEL International Reaches Analyst Target Price

In recent trading, shares of PAREXEL International Corp. have crossed above the average analyst 12-month target price of $63.95, changing hands for $64.16/share.

PRXL : 63.83 (+0.73%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More

Business Summary

Parexel International Corporation is one of the largest biopharmaceutical outsourcing organizations in the world, providing a broad range of knowledge-based contract research, medical marketing and consulting services to the worldwide pharmaceutical, biotechnology and medical device industries. With...

See More

Support & Resistance

2nd Resistance Point 64.57
1st Resistance Point 64.20
Last Price 63.83
1st Support Level 63.22
2nd Support Level 62.61

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.